Evaluation of the Effect of Dextro-Amphetamin Added to Physiotherapy in Patients After Stroke

Inclusion Criteria: * patients after first-ever ischemic stroke with a clinical relevant paresis of the upper and lower limb (general clinical muscle testing below level four) * correlation of clinical symptoms with a brain imaging (CT or MRI) * able to communicate with the neurological examiner and understand the aim/matter of the study (with or without aphasia) * start of the first oral application of the study drug between the fourteenth and 60th day after stroke onset * older than 13 years * given written informed consent (or two independent witnesses) Exclusion Criteria: * intracranial or (chronic) subdural hemorrhages * any additional neurological or psychiatric illnesses * instable arrythmia * not controlled or treated arterial hypertension * ensured cardioembolic event * anxiolytica, neuroleptica, or alpha-adrenergic antagonists or agonists respectively * certain anticonvulsiva or antihypertonica * manifest hyperthyreosis * dementia or terminal illnesses * epilepsy, phaeochromocytoma or glaucoma * women known to be pregnant or lactating